UnitedHealth Group shares climbed 7.3% over the past week as retail sentiment on Reddit and X swung from deeply bearish to neutral. Sentiment scores plunged to 18 in November following the CEO’s December shooting incident, surged to a peak of 82 in late December, and have since settled at 42 out of 100. Engagement on r/WallStreetBets remained negative during high-volatility periods, while r/options traders highlighted LEAPS and deep in-the-money call positions, one of which lost nearly $3,000 when the stock fell to 310 before rebounding. Institutional backing from Berkshire Hathaway’s 5 million-share holding and trading near both the 50- and 200-day moving averages have provided additional validation.

The Federal Trade Commission has approved a 14-day suspension of its administrative proceedings against UnitedHealth’s OptumRx unit, delaying the evidentiary hearing until July 1 and pushing back all discovery and filing deadlines. The original complaint, filed in September 2024, accuses pharmacy benefit managers of anti-competitive practices that inflated insulin prices through rebate structures. A second interim report released in January 2025 alleged markups of hundreds to thousands of percent on specialty generic drugs. Settlement negotiations are now thought to be underway as political scrutiny intensifies.

CEO Stephen Hemsley testified before House panels that hospital consolidation, rising facility fees and drug prices are the primary drivers of U.S. health care spending—not insurers. He pledged to eliminate and rebate UnitedHealth’s profits on Affordable Care Act exchange coverage this year, without detailing the financial impact. UnitedHealth serves nearly 10 million Medicare Advantage members and one million ACA enrollees, negotiated approximately $300 billion in provider discounts last year and claimed savings of about $35 billion through fraud and waste reduction. Hemsley also urged policy reforms such as site-neutral payments, patent reform and standardized broker compensation to realign incentives with consumer interests.